Christine Antalik - British Amer Chief Financial Officer

BTI Stock  CAD 0.01  1.24  99.60%   

CFO

Ms. Christine Antalik is Chief Financial Officer of the Company. Antalik is the managing member of Founders Bridge Advisors, LLC, a business advisory firm located in Connecticut, and has served as chief financial officer of Aeromics, Inc. since October 2016. Previously, Antalik served as chief financial officer of SurgiQuest, Inc. where she led the 265 million acquisition of SurgiQuest, Inc. by CONMED Corporation after filing the company public S1 statement. Antalik closed a 108 million initial public offering as the vice president of finance and controller at HigherOne, Inc., a financial technology company. Prior to HigherOne, Antalik served as controller for Tangoe, Inc., a software service company. As chief financial officer and treasurer of Hematech, LLC, Antalik formed a joint venture with a key services provider to mitigate business risk and ultimately steered the company to a successful exit, being acquired by Kirin Brewery Company, Limited. Antalik also previously served as controller and senior manager of litigation support and business valuation for Centerprise Advisors, Inc., a national consulting and accounting advisory firm, where she provided expert witness reports in economic damages cases, business valuations and forensic accounting services. Antalik earned her bachelor of science degree in business administration from Western New England College, Springfield, Mass. since 2019.
Tenure 5 years
Address 157 Church Street, New Haven, CT, United States, 06510
Phone203 533 7082
Webhttps://www.bioasis.us

British Amer Management Efficiency

The company has return on total asset (ROA) of (0.8058) % which means that it has lost $0.8058 on every $100 spent on assets. This is way below average. British Amer's management efficiency ratios could be used to measure how well British Amer manages its routine affairs as well as how well it operates its assets and liabilities. At this time, British Amer's Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to climb to 1.54 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (6.59). At this time, British Amer's Non Current Assets Total are fairly stable compared to the past year. Intangible Assets is likely to climb to about 452.7 K in 2024, whereas Total Current Assets are likely to drop slightly above 711.9 K in 2024.
biOasis Technologies has accumulated 1.9 M in total debt with debt to equity ratio (D/E) of 0.31, which is about average as compared to similar companies. biOasis Technologies has a current ratio of 1.67, which is within standard range for the sector. Debt can assist British Amer until it has trouble settling it off, either with new capital or with free cash flow. So, British Amer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like biOasis Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for British to invest in growth at high rates of return. When we think about British Amer's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 4 records

CFO Age

Rod BolgerRoyal Bank of
N/A
Riaz AhmedToronto Dominion Bank
N/A
Kelvin CFAToronto Dominion Bank
N/A
Kelvin TranToronto Dominion Bank
N/A
Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company was founded in 2007 and is based in New Haven, Connecticut. British Amer operates under Biotechnology classification in Exotistan and is traded on Commodity Exchange. biOasis Technologies (BTI) is traded on TSX Venture Exchange in Canada and employs 15 people. British Amer is listed under Biotechnology category by Fama And French industry classification.

Management Performance

biOasis Technologies Leadership Team

Elected by the shareholders, the British Amer's board of directors comprises two types of representatives: British Amer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of British. The board's role is to monitor British Amer's management team and ensure that shareholders' interests are well served. British Amer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, British Amer's outside directors are responsible for providing unbiased perspectives on the board's policies.
David Wurzer, Independent Director
Doug Williams, Executive Vice-President Chief Business Officer
David Jenkins, Chief Officer
Mario Saltarelli, Non-Executive Director
Graeme Dick, Director Relations
Doug MBA, Exec Officer
Christine Antalik, Chief Financial Officer
John Curran, Independent Director
Kim Elton, Director Marketing
Caroline Dircks, Chief Operating Officer
Deborah Rathjen, Executive Chairman of the Board, President, Chief Executive Officer
Aaron Elton, Director Marketing
Mei Tian, VP Research
Dave Jenkins, Chief Officer
B FTSE, CEO Chairman

British Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is British Amer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for British Stock Analysis

When running British Amer's price analysis, check to measure British Amer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy British Amer is operating at the current time. Most of British Amer's value examination focuses on studying past and present price action to predict the probability of British Amer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move British Amer's price. Additionally, you may evaluate how the addition of British Amer to your portfolios can decrease your overall portfolio volatility.